Skip to content

Solas BioVentures Management

Private funds

Chattanooga, TNCRD 322344Updated

Solas BioVentures Management is an investment adviser based in Chattanooga, TN, registered with the SEC since 2025. It provides investment management. Its clients include pooled investment vehicles. Its regulatory assets under management total $165 million, as filed on 1 October 2026.

12
Clients
Not reported
AUM per individual client
5
Advisory staff
2
Offices

From Form ADV filed 1 October 2026SEC record

Services and clients

Solas BioVentures Management provides portfolio management for pooled vehicles. The firm advises 12 private funds.

Solas BioVentures Management reports 12 pooled investment vehicles. These counts refer to investment vehicles, rather than the individual investors in them. Of its assets, 100.0% ($165M across 12 accounts) are managed with discretion.

Clients and assets by client type
Clients12 clients
Assets$165M
Share of clients and assets by client type
Client typeClientsAssets
Pooled investment vehicles100%100%
Client breakdown and activity details
Pooled investment vehicles
Clients
12
Regulatory AUM
$165M
AUM share
100.0%
Avg. per client
$13.7M

Total

Clients
12
Regulatory AUM
$165M
AUM share
100%
Avg. per client
$13.7M
Clients outside the U.S.
0%
Clients advised without assets under management last fiscal year
0
Private funds advised
12

Fees and minimums

Solas BioVentures Management is paid through a percentage of assets under management and performance-based fees; its fees and minimums are set out in its brochures on the SEC website.

Ownership and people

Charles Adair owns 50% to 75% of Solas BioVentures Management. The leadership team of Solas BioVentures Management includes Chief Compliance Officer Karey Williams. It has 6 employees, 5 of them in advisory roles.

Leadership

  • Karey Williams
    Chief Compliance Officer
  • David Belitz
    Manager
  • Michael Hoey
    Member
  • Charles Adair
    Manager
  • Mark Hackett
    Manager

Staff

  • 6 employees
  • 5 in advisory functions
Who owns the firm
Solas Bioventures Management, LLC· the adviser
  • Charles Adair

    Control person · since March 2020

    Owns 50% to 75% of Solas Bioventures Management, LLC
  • Mark Hackett

    Control person · since March 2020

    Owns 10% to 25% of Solas Bioventures Management, LLC
  • Michael Hoey

    Control person · since March 2020

    Owns 10% to 25% of Solas Bioventures Management, LLC

Offices and registration details

Besides its headquarters, Solas BioVentures Management has 1 office, with 2 listed addresses across 2 states.

Listed office addresses by state

Tennessee · 1 listed address

  • 412 Georgia Avenue, Suite 201, ChattanoogaHQ

Contact and registration details

Legal name
Solas Bioventures Management, LLC
Headquarters
412 Georgia Avenue, Suite 201, Chattanooga, TN 37403
SEC file
801-134738
Structure
Delaware LLC
Fiscal year end
December

Custodians

Solas BioVentures Management has custody of client assets.

Common questions

How many clients does Solas BioVentures Management have?

Solas BioVentures Management has 12 clients and manages $165 million for them, as of October 2026. They include 12 pooled investment vehicles.

Source: Form ADV Part 1A, Items 5.D and 5.F, filed 1 October 2026

What services does Solas BioVentures Management offer?

Solas BioVentures Management provides portfolio management for pooled vehicles.

Source: Form ADV Part 1A, Item 5.G, from the SEC's 2 October 2026 data file

How many financial advisors does Solas BioVentures Management have?

Solas BioVentures Management has 0 investment adviser representatives registered with state securities authorities, out of 6 employees, and 5 perform investment advisory functions. None are registered representatives of a broker-dealer or licensed insurance agents.

Source: Form ADV Part 1A, Items 5.A and 5.B, from the SEC's 2 October 2026 data file

Who owns Solas BioVentures Management?

Solas BioVentures Management’s direct owners are Charles Adair (50% to 75%), Mark Hackett (10% to 25%) and Michael Hoey (10% to 25%).

Source: Form ADV Part 1A, Schedules A and B, filed 1 October 2026

How does Solas BioVentures Management get paid?

Solas BioVentures Management is paid through a percentage of assets under management and performance-based fees. Its Form ADV lists no commissions among how it is paid.

Source: Form ADV Part 1A, Item 5.E, from the SEC's 2 October 2026 data file

How do I contact Solas BioVentures Management?

Solas BioVentures Management’s main office is at 412 Georgia Avenue, Suite 201, Chattanooga, TN 37403. Its phone number is 423-243-3460. Its website is solasbio.com.

Source: Form ADV Part 1A, Item 1.F, filed 1 October 2026

Sources and methodology

  1. Form ADV Part 1A, amendment filed 1 October 2026. Items 1, 5, 9, 11 and Schedules A, B and D.
  2. IAPD firm record, CRD 322344.

Retrieved 15 October 2026. All are published by the SEC and may have been amended since. Disciplinary history is not yet shown here. The SEC publishes the complete record, including any disciplinary events, and it is the authoritative place to check one.

Download source data (JSON)How this directory is compiledReport a correction